Biovica International AB Cash Flow Statement

Financials in millions SEK. Fiscal year is May - April.

Millions SEK. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 31, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Net Income	-71.51	-87.62	-124.82	-110.49	-60	-39.48
Depreciation & Amortization	4.12	4.51	4.34	4.44	2.66	2.76
Other Amortization	4.34	4.34	5.09	3.78	3.78	3.38
Loss (Gain) From Sale of Assets	0	0	-	-	-	-
Other Operating Activities	0.13	1.67	-1.9	-0.05	-0.28	-0.2
Change in Accounts Receivable	-3.03	-0.22	-0.4	-0.72	-1.73	-0.35
Change in Inventory	-0.95	-0.09	-0.59	0.1	-1.01	-0.13
Change in Other Net Operating Assets	2.25	-7.95	3.71	8.31	4.46	-0.38
Operating Cash Flow	-64.65	-85.37	-114.58	-94.64	-52.13	-34.41
Capital Expenditures	-0.26	-0.29	-0.15	-1.21	-0.41	-
Sale (Purchase) of Intangibles	-	-	-	-1.57	-2.99	-3.56
Investment in Securities	-	-	-0.44	-	-	-
Investing Cash Flow	-0.26	-0.29	-0.59	-2.78	-3.4	-3.56
Long-Term Debt Repaid	-	-3.31	-2.97	-2.9	-1.34	-1.29
Net Debt Issued (Repaid)	-3.24	-3.31	-2.97	-2.9	-1.34	-1.29
Issuance of Common Stock	122.3	35.84	99.12	150.09	1.2	151.1
Other Financing Activities	-8.93	-1.6	-16.65	-25.18	-	-7.15
Financing Cash Flow	110.14	30.93	79.5	122.01	-0.14	142.66
Foreign Exchange Rate Adjustments	-0.51	-0.26	0.74	-0.05	0.09	-0.11
Miscellaneous Cash Flow Adjustments	-0	-0	0	-0	0	-
Net Cash Flow	44.71	-54.99	-34.92	24.54	-55.57	104.59
Free Cash Flow	-64.91	-85.65	-114.72	-95.85	-52.53	-34.41
Free Cash Flow Margin	-594.17%	-990.56%	-1572.60%	-1839.30%	-1030.44%	-460.01%
Free Cash Flow Per Share	-0.35	-0.93	-1.96	-2.75	-1.85	-1.21
Cash Interest Paid	0.22	0.22	0.29	0.45	0.08	0.06
Cash Income Tax Paid	0.6	0.6	2.23	-0.09	0.16	0.45
Levered Free Cash Flow	-39.31	-53.86	-69.44	-55.75	-33.34	-23.86
Unlevered Free Cash Flow	-39.31	-53.72	-69.26	-55.57	-33.29	-23.82
Change in Working Capital	-1.73	-8.25	2.72	7.69	1.72	-0.86